The information contained on this web page is only a summary of information presented in more detail in the Notice of
Proposed Class Action Settlement (the “Notice”), which you can access by clicking here
. Since this website is just a summary, you should review the Notice for additional details.
Court-appointed Lead Plaintiff, Barbara Forman, on behalf of herself and all Settlement Class Members, have reached a proposed settlement of the Action for $2.1 million in cash that, if approved, will resolve all claims in the Litigation (the “Settlement”).
If you are a member of the Class, your rights will be affected and you may be eligible for a payment from the Settlement, unless you timely request to be excluded. The Class consists of:
all persons or entities who purchased or otherwise acquired securities of Meridian Bioscience, Inc. (“Meridian” or the “Company”) between March 24, 2016 and October 23, 2017, inclusive (the “Class Period”), and were damaged thereby, except for certain persons and entities who are excluded from the Class by definition (see paragraph 6 of the Notice
) or who request exclusion pursuant to the instructions set forth in the Notice (see paragraph 14 of the Notice ).
Please read the Notice to fully understand your rights and options. Copies of the Notice and Claim Form
can be found on the menu at the left of this page.
Payments to eligible claimants will be made only if the Court approves the Settlement and a plan of allocation, and only after any appeals are resolved, and after the completion of all claims processing. Please be patient, as this process will take some time to complete.
IMPORTANT DATES |
February 4, 2020 | Claim Filing Deadline. Claim Form
must be postmarked no later than February 4, 2020 to be eligible for a payment from the Settlement. |
February 17, 2020 | Exclusion Deadline. To exclude yourself from the Class, you must submit a written request for exclusion so that it is received no later than February 17, 2020, in accordance with the instructions in the Notice
. |
February 17, 2020 | Objection Deadline. Any objections to the proposed Settlement, the proposed Plan of Allocation, the application by Lead Counsel for an award of fees and reimbursement of expenses, or the application for an award to Plaintiff must be received no later than February 17, 2020, in accordance with the instructions in the Notice
. |
March 16, 2020 at 2:00 p.m. | The Settlement Hearing. The Settlement Hearing will be held on March 16, 2020 at 2:00 p.m., before the Honorable Susan J. Dlott in Courtroom 7, Room 117 of the United States District Court for the Southern District of Ohio, Potter Stewart U.S. Courthouse, 100 East Fifth Street, Cincinnati, Ohio 45202. The Settlement Hearing will be held by the Court to consider whether the proposed Settlement of the Action on the terms and conditions provided in the Stipulation is fair, reasonable, and adequate and should be approved by the Court. |
Please read the Notice
carefully. If you have questions, you may call the Meridian Bioscience Securities Litigation Help Line at 800-331-8642 or email info@meridiansecuritieslitigation.com